other hematologic conditions	are	blood disorders
other hematologic conditions	include	anemia
other hematologic conditions	include	leukopenia
other hematologic conditions	include	thrombocytopenia
anemia	is a	low hemoglobin
leukopenia	is a	low white blood cell
thrombocytopenia	is a	low platelet
anemia	causes	fatigue
leukopenia	causes	infection
thrombocytopenia	causes	bleeding
iron deficiency	causes	anemia
folate deficiency	causes	anemia
vitamin B12 deficiency	causes	anemia
hemolytic anemia	is a	red cell destruction
sickle cell disease	is a	hemolytic anemia
thalassemia	is a	hemolytic anemia
aplastic anemia	is a	bone marrow failure
myelodysplastic syndrome	is a	clonal marrow disorder
leukemia	is a	malignant white cell
acute lymphoblastic leukemia	is a	childhood leukemia
acute myeloid leukemia	is a	adult leukemia
chronic lymphocytic leukemia	is a	adult leukemia
chronic myeloid leukemia	is a	adult leukemia
myeloma	is a	plasma cell cancer
polycythemia vera	is a	red cell excess
essential thrombocythemia	is a	platelet excess
myelofibrosis	is a	marrow scarring
hemophilia	is a	clotting factor deficiency
von Willebrand disease	is a	platelet adhesion defect
platelet function disorder	is a	bleeding tendency
coagulation factor deficiency	is a	bleeding disorder
deep vein thrombosis	is a	clotting event
pulmonary embolism	is a	clot migration
venous thromboembolism	is a	clot complication
antithrombin deficiency	increases	thrombosis risk
protein C deficiency	increases	thrombosis risk
protein S deficiency	increases	thrombosis risk
factor V Leiden	is a	genetic thrombophilia
prothrombin G20210A	is a	genetic thrombophilia
antiphospholipid syndrome	is a	autoimmune thrombosis
lupus anticoagulant	is a	clotting antibody
platelet transfusion	treats	thrombocytopenia
red blood cell transfusion	treats	anemia
bone marrow transplant	treats	leukemia
hematopoietic stem cell transplant	treats	myelodysplastic syndrome
chemotherapy	treats	leukemia
radiation therapy	treats	lymphoma
immunotherapy	treats	myeloma
targeted therapy	treats	chronic myeloid leukemia
tyrosine kinase inhibitor	treats	chronic myeloid leukemia
rituximab	treats	chronic lymphocytic leukemia
lenalidomide	treats	myeloma
bortezomib	treats	myeloma
hydroxyurea	treats	polycythemia vera
interferon alpha	treats	essential thrombocythemia
aggressive disease	predicts	poor survival
low platelet count	predicts	bleeding risk
high white blood cell count	predicts	infection risk
low hemoglobin	predicts	mortality
bone marrow biopsy	diagnoses	hematologic disorder
complete blood count	monitors	blood disorder
flow cytometry	diagnoses	leukemia
cytogenetic analysis	predicts	prognosis
next‑generation sequencing	identifies	mutations
FLT3 mutation	predicts	poor outcome
NPM1 mutation	predicts	favorable outcome
TP53 mutation	predicts	poor outcome
BCR‑ABL fusion	predicts	response to TKIs
JAK2 V617F	predicts	response to hydroxyurea
CALR mutation	predicts	prognosis in essential thrombocythemia
ASXL1 mutation	predicts	poor outcome
clonal evolution	predicts	relapse
minimal residual disease	predicts	relapse
spleen size	predicts	symptom burden
fatigue severity	predicts	quality of life
bleeding episodes	predict	readmission
infection episodes	predict	readmission
hospital length of stay	correlates	disease severity
age	predicts	mortality
gender	predicts	survival
comorbidities	predict	complications
BMI	predicts	treatment toxicity
renal function	predicts	drug dosing
liver function	predicts	drug metabolism
pharmacogenomics	guides	drug choice
adherence	predicts	remission
supportive care	reduces	mortality
early intervention	improves	survival
clinical trial enrollment	improves	outcomes
patient education	reduces	readmission
telehealth monitoring	improves	adherence
social support	improves	quality of life
nutrition	improves	anemia
exercise	improves	fatigue
stress management	improves	quality of life
vaccination	reduces	infection risk
screening	detects	early disease
risk assessment	guides	prophylaxis
anticoagulation	prevents	thrombosis
antiplatelet therapy	prevents	arterial thrombosis
